Related Experiment Video
Updated: Jan 30, 2026

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
Published on: February 7, 2025
Stems cells, big data and compendium-based analyses for identifying cell types, signalling pathways and gene
Md Humayun Kabir1,2, Michael D O'Connor3,4
1School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Abstract:
Identification of new drug and cell therapy targets for disease treatment will be facilitated by a detailed molecular understanding of normal and disease development. Human pluripotent stem cells can provide a large in vitro source of human cell types and, in a growing number of instances, also three-dimensional multicellular tissues called organoids. The application of stem cell technology to discovery and development of new therapies will be aided by detailed molecular characterisation of cell identity, cell signalling pathways and target gene networks. Big data or 'omics' techniques-particularly transcriptomics and proteomics-facilitate cell and tissue characterisation using thousands to tens-of-thousands of genes or proteins. These gene and protein profiles are analysed using existing and/or emergent bioinformatics methods, including a growing number of methods that compare sample profiles against compendia of reference samples. This review assesses how compendium-based analyses can aid the application of stem cell technology for new therapy development. This includes via robust definition of differentiated stem cell identity, as well as elucidation of complex signalling pathways and target gene networks involved in normal and diseased states.
Insights
This review explores how analyzing large datasets of gene and protein profiles from stem cells and organoids, using bioinformatics methods, can accelerate the discovery of new drug and cell therapies for diseases. Such compendium-based analyses enhance understanding of cell identity and disease pathways.
Area of Science:
- Biotechnology
- Genomics
- Proteomics
Background:
- Human pluripotent stem cells and organoids offer a valuable in vitro source for studying human cell types and tissues.
- Understanding molecular mechanisms of normal and disease development is crucial for identifying new therapeutic targets.
Purpose of the Study:
- To review how compendium-based analyses of 'omics' data can support stem cell technology applications in developing new therapies.
- To highlight the role of molecular characterization in defining cell identity, signaling pathways, and gene networks.
Main Methods:
- Utilizing big data ('omics') techniques like transcriptomics and proteomics for cell and tissue characterization.
- Applying bioinformatics methods, including compendium-based analyses, to interpret large-scale gene and protein profiles.
- Comparing sample profiles against reference compendia to understand biological states.
Main Results:
- Compendium-based analyses facilitate robust definition of differentiated stem cell identity.
- These methods aid in elucidating complex signaling pathways and target gene networks in both normal and diseased states.
- The approach supports the application of stem cell technology for novel therapy development.
Conclusions:
- Detailed molecular characterization using 'omics' and bioinformatics is key to advancing stem cell-based therapies.
- Compendium-based analysis provides a powerful framework for drug and cell therapy target discovery.
- This strategy enhances the translation of stem cell research into clinical applications.
Related Concept Videos
What is Cell Signaling?
Cell Specific Gene Expression
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Cis-regulatory Sequences

